New data show high diagnostic performance for ovarian, endometrial, and cervical cancers, with a targeted assay designed to run on existing clinical laboratory equipment.
Read More
Diagnostic lab, molecular, and genomics claim denials rose 40% to 11.2% in 2025, driven by insurer automation and more prior authorization rejections, according to XiFin’s 2026 Payor Denial Impact Report.
Read More
Clinisys has integrated document intelligence into its Laboratory Solution platform, enabling labs to convert unstructured documents into searchable, governed data for improved workflow efficiency and reduced manual entry.
Read More
New data presented at ASTRO 2026 show Artera’s multimodal AI prostate cancer biomarker delivers consistent prognostic results across diverse patient populations, supporting its use in personalized treatment decisions, according to five abstracts.
Read More
Castle Biosciences’ TissueCypher test informed management changes in 90% of non-dysplastic Barrett’s esophagus cases in a 30-patient study at Keck Medical Center, according to results published in Foregut.
Read More